Format

Send to

Choose Destination
See comment in PubMed Commons below
J Psychiatr Pract. 2004 Jul;10(4):239-48.

The role of monoamine oxidase inhibitors in current psychiatric practice.

Author information

  • 1The Johns Hopkins Hospital, Dept. of Psychiatry, Baltimore, MD 21287-7131, USA.

Abstract

The use of monoamine oxidase inhibitors (MAOIs) by psychiatrists has declined over the past several decades with the expansion of psychiatrists' pharmacologic armamentarium. This trend has also been driven by concern about food and drug interactions and side effects, as well as waning physician experience with these medications. Many psychiatrists, in fact, never prescribe MAOIs. Recent research has liberalized the MAOI diet and identified symptom presentations more likely to respond to these medications. Thus, clinicians must continue to familiarize themselves with the properties of and indications for prescribing MAOIs.

PMID:
15552546
PMCID:
PMC2075358
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins Icon for PubMed Central
    Loading ...
    Support Center